Sudarshan Pharma Industries Ltd

Allotment

It is hereby informed that the members of the FCCB COmmittee of the COmpany, have at their meeting held today, 19/Aug/2026, have approved allotment of 48,11,730 fully paid-up equity shares ....

Company Update / Allotment of Equity Shares View filing →

Newspaper Publication

Please find enclosed the newspaper advertisement for the Unaudited Standalone and Consolidated Financial Results for the quarter ended 30/June/2026 published in (i) Mumbai Lakshdeep (Marathi) ....

Company Update / Newspaper Publication View filing →

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 14, 2026 for Vasantrai Ratilal ....

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

FCCB Committee Meeting On Wednesday, 19-August-2026

A Meeting of the FCCB Committee of the Company is scheduled on Wednesday, 19-August-2026 to consider and approve conversion a portion of funds raised through FCCBs into equity shares and ....

Company Update / General View filing →

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 08, 2026 for Hemal Vasantrai Mehta

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.

The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on July 14, 2026 for Hemal Vasantrai Mehta

Insider Trading / SAST / Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 View filing →

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Please find attached copy of certificates under Regulation 74(5) of SEBI (Depository And Participants) Regulations, 2018, received from Kfin Technologies Limited for the quarter ended 30/June/2026.

Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

Closure of Trading Window

The Trading Window of the Company shall remain closed with effect from 01/July/2026 untill the expiry of 48 hours after the declaration of the financial results for the quarter ended 30/June/2026.

Insider Trading / SAST / Closure of Trading Window View filing →

Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

Please find enclosed the voting results on the business transacted through postal ballot notice dated 21/May/2026 which was open for voting from 26/May/2026 to 24/June/2026.

AGM/EGM / Postal Ballot View filing →

Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

Please find enclosed the Scrutinizer's Report on the business transacted through postal ballot notice dated 21/May/2026 which was open for voting from 26/May/2026 to 24/June/2026.

AGM/EGM / Postal Ballot View filing →

Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Thursday, 18Th June, 2026

Sudarshan Pharma Industries Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2026 ,inter alia, to consider and approve proposal for raising ....

Board Meeting / Board Meeting View filing →

Allotment

Pursuant to Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, the Warrants Committee of the Board of Directors of the Company have at their meeting ....

Company Update / Allotment of Equity Shares View filing →

Meeting Of Warrants Committee Of The Company Scheduled On Thursday, 11/June/2026 Now Postponed To Friday, 12/June/2026

We wish to inform you that the meeting of the Warrants Committee of the Company originally scheduled on 11/June/2026 has been postponed and will now be held on Friday, 12/June/2026.

Company Update / General View filing →

Meeting Of Warrants Committee Of The Company On Thursday, 11/June/2026

Pursuant to Regulation 29 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, a Meeting of the Warrants Committee of the Company is scheduled to be held on Thursday, ....

Company Update / General View filing →

Intimation As Per Regulation 31 (1) & 31 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations, 2011

Please find enclosed disclosure under Regulation 31(2) of SEBI (Subtsantial Acquisition of Shares and Takeovers) REgulations, 2011 in connection with intimation of pledge.

Company Update / General View filing →

Reply To The Email Dated 18Th May 2026 Seeking 'Discrepancies In Financial Results'

We refer to email dated 18/May/2026, referring to discrepancies in financial results for the QUARTER and financial year ended 31/March/2026. We hereby submit the financial results for ....

Company Update / General View filing →